ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,00%
Dow Jones
44 882,13
0,38%
DAX
21 727,20
0,48%
Brent Oil
76,235
0,24%
Bitcoin
104 474,99
-0,25%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Xeris Biopharma Inc (0A8E) Cours

Xeris Biopharma Inc

Xeris Biopharma Inc (0A8E)

LSE
0,00
0,00
(0,00%)
Fermé 31 Janvier 5:30PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
-
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
-
Clôture Veille
0,00
Ouverture
-
Dernière Transaction
1200
@
3.665
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
138 125 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-8,10
Bénéfice par action (BPA)
-0,45
Chiffre d'affairess
163,91M
Bénéfice net
-62,26M

À propos de Xeris Biopharma Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.xerispharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Xeris Biopharma Inc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0A8E. Le dernier cours de clôture d'Xeris Biopharma était de US$0,00. Au cours de la dernière année, les actions de Xeris Biopharma ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Xeris Biopharma compte actuellement 138 125 000 actions en circulation. Xeris Biopharma a un ratio cours/bénéfice (ratio PE) de -8.10.

0A8E Dernières nouvelles

Plus de nouvelles

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 07 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

07 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 06 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

06 Octobre 2021
UK Regulatory

Lazard Asset Management Form 8.3 - Xeris Pharmaceuticals, Inc

Lazard Asset Management 06 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS...

06 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3 Amend

J.P. Morgan Securities LLC 05 October 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

05 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 05 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

05 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 04 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

04 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 01 October 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

01 Octobre 2021
UK Regulatory

Morgan Stanley Smith Barney LLC Form 8.3 - XERIS PHARMACEUTICALS INC

Morgan Stanley Smith Barney LLC 01 October 2021 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

01 Octobre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 AMENDMENT FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY...

30 Septembre 2021
UK Regulatory

J.P. Morgan Securities LLC Xeris Pharmaceuticals, Inc 8.3

J.P. Morgan Securities LLC 30 September 2021 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...

30 Septembre 2021
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0A8E - Frequently Asked Questions (FAQ)

What is the current Xeris Biopharma share price?
The current share price of Xeris Biopharma is US$ 0,00
How many Xeris Biopharma shares are in issue?
Xeris Biopharma has 138 125 000 shares in issue
What is the 1 year trading range for Xeris Biopharma share price?
Xeris Biopharma has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Xeris Biopharma?
The price to earnings ratio of Xeris Biopharma is -8,1
What is the cash to sales ratio of Xeris Biopharma?
The cash to sales ratio of Xeris Biopharma is 3,08
What is the reporting currency for Xeris Biopharma?
Xeris Biopharma reports financial results in USD
What is the latest annual turnover for Xeris Biopharma?
The latest annual turnover of Xeris Biopharma is USD 163,91M
What is the latest annual profit for Xeris Biopharma?
The latest annual profit of Xeris Biopharma is USD -62,26M
What is the registered address of Xeris Biopharma?
The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Xeris Biopharma website address?
The website address for Xeris Biopharma is www.xerispharma.com
Which industry sector does Xeris Biopharma operate in?
Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
0
0A1UUber Technologies Inc
US$ 66,60
(0,00%)
0
0A2IH World Group Ltd
US$ 0,00
(0,00%)
0
0A2DCrh Plc
US$ 0,00
(0,00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0,00
(0,00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0,00
(0,00%)
0
0A1UUber Technologies Inc
US$ 66,60
(0,00%)
0
0R24Intel Corp
US$ 19,525
(0,00%)
13,6k
0HCIAlibaba Group Holding Ltd
US$ 101,90
(0,00%)
1,73k
0R2VApple Inc
US$ 237,50
(0,00%)
1,48k
0QYPMicrosoft Corp
US$ 417,50
(0,00%)
868
0R9UPaypal Holdings Inc
US$ 89,10
(0,00%)
424

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0A8E
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces